Startups
Access to Medicine Foundation
Edit

Access to Medicine Foundation

https://accesstomedicinefoundation.org/
Last activity: 19.11.2024
Active
Categories: DataDevelopmentDiagnosticsEnergyTechHealthTechIndustryMedtechNonprofitProductPublic
The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. Over the past two decades, we have demonstrated the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products. Our tried-and-tested approach involves defining the actions that healthcare companies should take, analysing what companies are actually doing, and promoting best practices. To turn our insights into action, we engage with the companies we evaluate, as well as with stakeholders across the private and public sectors. Our power to make an impact has been proven in the case of Big Pharma, as demonstrated by the success of the Access to Medicine Index. We have now begun to further expand our scope and use our change-making model to move companies across a wider range of healthcare sectors. This encompasses core groups of companies across five sectors: Big Pharma, vaccine manufacturers, generic medicine manufacturers, diagnostic companies and medical gas companies. Learn more about we are taking access to the next level 👉 accesstomedicinefoundation.org/news/taking-access-to-the-next-level-mobilising-five-essential-healthcare-sectors
Followers
11.84K
Website visits
11.6K /mo.
Mentions
15

Overview

Location
Netherlands, North Holland, Amsterdam
Employees
11-50
Founded date
2003

Mentions in press and media 15

DateTitleDescription
Sign up to seeSign up to seeSign up to see
May 23, 2024New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistanceAMSTERDAM, May 23, 2024 /PRNewswire/ -- The race to create replacement antibiotics and antifungals to combat superbugs is falling dangerously short, putting people across the world at risk. However, a shift in research and development (R&am...
May 23, 2024New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistanceAMSTERDAM, May 23, 2024 /PRNewswire/ -- The race to create replacement antibiotics and antifungals to combat superbugs is falling dangerously short, putting people across the world at risk. However, a shift in research and development (R&am...
Oct 24, 2023Insulin is increasingly affordable in the U.S. What about the rest of the world?In March, Eli Lilly, Novo Nordisk, and Sanofi — the world’s three largest insulin manufacturers — committed to reducing the U.S. list price of insulin, a drug that millions of people require to live. Following two decades of sharp increases...
Jul 12, 2023Sickle cell cures are coming. African children can’t be left behindThe treatment of sickle cell disease is on the cusp of a historic breakthrough, with makers of two gene-based treatments for the debilitating blood disorder hoping for regulatory approval this year. But for those with sickle cell in sub-Sah...
Feb 28, 2023Redefining sustainability in health care: putting patients before profitsSustainability appears to be a priority for most companies today, with teams of staff at major corporations dedicated to it and to providing strong messaging on its importance. But in terms of the real, practical implications for consumers,...
Jun 1, 2022Pfizer’s Not-For-Profit Model For Sales Of Products To Low- And Lower-Middle-Income Countries May Be A Game Changer In Global HealthPfizer CEO Albert Bourla gestures during a session at the World Economic Forum (WEF) annual meeting ... [+] in Davos on May 25, 2022. - Pfizer said it would sell its patented drugs at a not-for-profit basis to dozens of low- and lower-middl...
Nov 18, 2021A lack of access: Pharma is failing to ensure new antibiotics will be available to poor countries, analysis findsAlthough the pharmaceutical industry is making modest progress in countering resistance to superbugs, drug companies are not doing enough to ensure greater access to lifesaving antibiotics in low and middle-income countries, a new analysis ...
Jan 26, 2021Drug­mak­ers 'inch­ing ahead' in in­creas­ing ac­cess to drugs world­wide, with Glax­o­SmithK­line lead­ing the packTop drug de­vel­op­ers are “inch­ing ahead” in im­prov­ing ac­cess to much-need­ed drugs around the world — an is­sue that has been un­der­scored by the Covid-19 pan­dem­ic. But there’s still more work to do, Ac­cess to Med­i­cine Foun­da­t...
Sep 28, 2020Global investors must support pharma solidarity and collaboration in the response to Covid-19The prospect of having the first supplies of at least a few effective Covid-19 medicines and vaccines by the end of 2020 is a key driver of recent market optimism. New treatments and vaccines are among the best bets for our societies agains...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Access to Medicine Foundation

When was Access to Medicine Foundation founded?

Access to Medicine Foundation was founded in 2003.

Is Access to Medicine Foundation still active?

Yes, Access to Medicine Foundation is active; its latest activity on Parsers VC dates from Nov 19, 2024.